Stay updated on Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.

Latest updates to the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedMassachusetts has been added as a participating site under the Locations section. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedAdded an explanatory note in Publications stating that publications are provided voluntarily by the person entering information and added Revision: v3.3.2. The earlier note stating 'These publications are provided voluntarily...' and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check52 days agoChange Detected- Removed the notice about government funding and operating status.SummaryDifference0.4%

- Check66 days agoChange DetectedNo additions or deletions detected between the screenshots; the study page content appears unchanged (title, eligibility criteria, and outcome measures remain the same). There were no changes to core content, names, pricing, stock, or time slot availability.SummaryDifference0.5%

- Check95 days agoChange DetectedUpdate headers: page now includes a government funding-lapse notice with operating-status guidance and links, and the version is upgraded to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check102 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.